|
Background publications
|
Murata, Konishi, Itoh: "FGF21 as an Endocrine Regulator in Lipid Metabolism: From Molecular Evolution to Physiology and Pathophysiology." in: Journal of nutrition and metabolism, Vol. 2011, pp. 981315, 2011 (PubMed).
Matuszek, Lenart-Lipińska, Duma, Solski, Nowakowski: "Evaluation of concentrations of FGF-21 - a new adipocytokine in type 2 diabetes." in: Endokrynologia Polska, Vol. 61, Issue 1, pp. 50-4, 2010 (PubMed).
Stein, Bachmann, Lössner, Kratzsch, Blüher, Stumvoll, Fasshauer: "Serum levels of the adipokine FGF21 depend on renal function." in: Diabetes Care, Vol. 32, Issue 1, pp. 126-8, 2008 (PubMed).
Ogawa, Kurosu, Yamamoto, Nandi, Rosenblatt, Goetz, Eliseenkova, Mohammadi, Kuro-o: "BetaKlotho is required for metabolic activity of fibroblast growth factor 21." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Issue 18, pp. 7432-7, 2007 (PubMed).
Kharitonenkov, Shiyanova, Koester, Ford, Micanovic, Galbreath, Sandusky, Hammond, Moyers, Owens, Gromada, Brozinick, Hawkins, Wroblewski, Li, Mehrbod, Jaskunas, Shanafelt: "FGF-21 as a novel metabolic regulator." in: The Journal of clinical investigation, Vol. 115, Issue 6, pp. 1627-35, 2005 (PubMed).
Nishimura, Nakatake, Konishi, Itoh: "Identification of a novel FGF, FGF-21, preferentially expressed in the liver." in: Biochimica et biophysica acta, Vol. 1492, Issue 1, pp. 203-6, 2000 (PubMed).
|
|
Product cited in:
|
Dushay, Chui, Gopalakrishnan, Varela-Rey, Crawley, Fisher, Badman, Martinez-Chantar, Maratos-Flier: "Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease." in: Gastroenterology, Vol. 139, Issue 2, pp. 456-63, 2010 (PubMed).
|